Search Results 1751-1760 of 11638 for total t4
Have total bilirubin <2.0 mg/dL; Have aspartate aminotransferase and alanine aminotransferase <3 times the upper limit of normal; Have serum creatinine ≤3 ...
Computed tomography (CT) scans of the chest, abdomen and pelvis with radionuclide bone scan OR whole body positron emission tomography (PET)/CT. History ...
The subject is unable to complete follow-up visits for the duration of the study. Echo Exclusion Criteria: A subject is excluded from the study if any of the ...
The patient can complete a baseline six-minute walk distance (6MWD) ≥ 150 m. The patient has had evidence of FEV1 ≥ 60% and FEV1/FVC ratio ≥ 60% during ...
Total bilirubin =< 1.5 X upper limit of normal (ULN) unless history of Gilbert's syndrome documented prior to first-line treatment of cancer and other liver ...
Participation eligibility · Subjects with total bilirubin > 2 times the upper limit of normal, and/or a known diagnosis or clinical suspicion of liver cirrhosis ...
Subjects must complete a minimum of 80% of the daily ePRO diary entry during the baseline period; Female subjects of childbearing potential and male subjects ...
Part 2: - To demonstrate overall safety and tolerability of GZ/SAR4027671 administered orally in early-stage Parkinson's disease patients carrying a GBA ...
Serum creatinine < 2.0 mg/dL; Total bilirubin < 2 x the institutional upper limit of normal (ULN); Aspartate aminotransferase (AST) or alanine ...
Phase 2: The primary objective of the study is to evaluate the clinical efficacy of sarilumab relative to the control arm in adult patients hospitalized with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!